Financhill
Back

Greek Organisation of Football Prognostics SA Vs. Akero Therapeutics Industry Stock Comparison

Buy
64

GOFPY
Greek Organisation of Football Prognostics SA

Last Price:
$11.49
Seasonality Move:
-1.87%
Buy
60

AKRO
Akero Therapeutics

Last Price:
$56.25
Seasonality Move:
34.97%
Buy
64
Greek Organisation of Football Prognostics SA (GOFPY) is a Buy

Is Greek Organisation of Football Prognostics SA a Buy, Sell or Hold?

  • The current Greek Organisation of Football Prognostics SA [GOFPY] share price is $11.49. The Score for GOFPY is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • GOFPY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
60
Akero Therapeutics (AKRO) is a Buy

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $56.19. The Score for AKRO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GOFPY Stock Price Chart

What is Greek Organisation of Football Prognostics SA's stock price today?

  • The Greek Organisation of Football Prognostics SA share price today is $11.49
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GOFPY is experiencing buying pressure, which is a positive indicator for future bullish movement.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $56.19
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight selling pressure.

GOFPY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.05 Buy
Relative Strength Index (14 RSI): 58.75 Buy
Chaikin Money Flow: 7043 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.81 - 11.41) Buy
Bollinger Bands (100): (9.24 - 11.26) Buy

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.45 Buy
Relative Strength Index (14 RSI): 67.53 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.33 - 55.87) Buy
Bollinger Bands (100): (40.08 - 52.38) Buy

GOFPY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.06 Buy
20-day SMA: 11.02 Buy
50-day SMA: 11.14 Buy
200-day SMA: 9.34 Buy
8-day EMA: 11.19 Buy
20-day EMA: 11.11 Buy
50-day EMA: 10.91 Buy
200-day EMA: 9.73 Buy

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 55 Buy
20-day SMA: 54.01 Buy
50-day SMA: 47.06 Buy
200-day SMA: 38.07 Buy
8-day EMA: 55.12 Buy
20-day EMA: 53.19 Buy
50-day EMA: 48.99 Buy
200-day EMA: 39.98 Buy

Greek Organisation of Football Prognostics SA Earnings Growth & GOFPY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.

Greek Organisation of Football Prognostics SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):